INTRODUCTION
Mdr1a/1b and Bcrp1/Abcg2 are two members of the ATP binding cassette transporter superfamily. They are highly expressed in hematopoietic stem cells (HSCs) and down-regulated upon hematopoietic maturation (1) (2) (3) (4) (5) . The expression of Mdr1a/ 1b (tightly linked genes in a single locus) confers low rhodamine 123 fluorescence, and the expression of Bcrp1 confers low Hoechst 33342 fluorescence, which results in the side population (SP) phenotype in HSCs (1, (6) (7) (8) (9) . Studies using Mdr1a/1b or Bcrp1 knock-out mice have shown that these two transporters protect HSCs against the toxicity of chemotherapeutic drugs such as mitoxantrone and possibly other naturally occurring xenobiotic substrates, but their relative role is undefined (9) (10) (11) . A potentially important role of Mdr1a/1b and/or Bcrp1 in the development of hematopoietic cells has been implicated by their conserved expression in HSCs and by overexpression studies. Overexpression of MDR1 in HSCs by retrovirus transduction led to HSC expansion, myeloproliferation, and leukemia (12, 13) , while overexpression of BCRP in HSCs disrupted their normal differentiation (1) . However, no abnormality in hematopoietic development has been observed in mice lacking either Mdr1a/ 1b or Bcrp1 (9, 14) . Because Mdr1a/1b and Bcrp1 share many substrates such as mitoxantrone, Hoechst 33342, and etoposide, it is unknown whether Mdr1a/1b and Bcrp1 perform redundant functions in hematopoietic development and in the protection of hematopoietic cells against xenobiotic substrates. To answer these questions, we generated mice lacking both Mdr1a/1b and Bcrp1 expression and examined their hematopoietic system specifically, as well as the sensitivity of hematopoietic cells from these mice to mitoxantrone, a known cytotoxic substrate for both transporters.
MATERIALS AND METHODS

Generation of
were generated by crossing M -/-B +/+ mice (Taconic, Germantown, NY, USA) (generated by Schinkel's group) (15) , which are on FVB background, with M +/+ B +/-mice generated in our laboratory and on a 129/C57BL6 mixed genetic background (9), through three breeding steps. All experiments were performed using mice between 6-14 weeks of age. Tail DNA samples from offspring were genotyped by PCR using primer pairs described elsewhere for Mdr1a and Mdr1b alleles (10); 5′-GTGCCACCATGTTCAACTTA-3′ and 5′-CTGCCAGAGTAGTGGAAGATT-3′ were used for a 376-bp fragment for the wild-type Bcrp1 allele; and 5′-AG-GCGACCTCTTCCAAGACT-3′ and 5′-GCAGCGCATC-GCCTTCTATC-3′ were used for a 561-bp fragment for the Bcrp1 -/-allele. Complete blood count (CBC) was obtained using 
Side Population Analysis and Antibody Labeling
Hoechst 33342 staining of bone marrow cells for side population (SP) cell analysis was essentially performed as previously described (7), except that 2.5 µg/mL of Hoechst were used to provide lower stringency for SP enumeration. After Hoechst staining, the cells were incubated with a cocktail of antibody containing fluorescein isothiocyanate (FITC)-conjugated CD3e, B220, 
Hematopoietic Progenitor Cell Assay
Bone marrow hematopoietic progenitor cells were enumerated as the number of colonies formed in a methylcellulose colony assay (M3534; Stem Cell Technologies, Vancouver, BC, Canada) in the presence of various concentrations of mitoxantrone after 7 days of culture. Mean (× -± SD); n = 6. RBC, red blood cell. Table 2 ). The lack of any detectable abnormality in HSCs from M -/-B -/-mice suggests that the myeloproliferation seen in MDR1 overexpression studies and the disrupted hematopoietic development seen in BCRP overexpression studies were due to a gain in function caused by dysregulated expression from the retroviral constructs.
RESULTS AND DISCUSSION
Generation
Mdr1a/1b Is Responsible for a Small Portion of Side Population Cells Without the K + S + L -Stem Cell Phenotype
Stem cells from a variety of tissues and species can be identified by a SP phenotype based on dual-emission analysis of Hoechst-stained cells (1, 7, 8, (17) (18) (19) (20) (21) (22) (23) . We have shown that Bcrp1 is exclusively responsible for the SP phenotype in phenotypically defined HSCs (9). However, residual SP cells remained in the bone marrow of B -/-M +/+ mice. To examine whether these residual SP cells were due to the expression of Mdr1a/1b, we performed SP analyses of bone marrow cells from M -/-B -/-mice. We used a lower Hoechst concentration (2.5 µg/mL) to provide a less stringent and more sensitive assay for Hoechst efflux to reveal the mild Hoechst efflux activity conferred by the expression of Mdr1a/1b, if any, in these cells. Indeed, there is a further decrease of SP cells in the bone marrow of M -/-B -/-mice compared to that of the M +/+ B -/-mice (0.01% vs. 0.033%; P < 0.001) (Figure 2 ) (Table 2) , and the majority of the residual SP cells in the M -/-B -/-bone marrow lack the K + S + L -stem cell phenotype, which confirmed that the expression of Mdr1 can confer an SP phenotype to some mature cells. Another observation in the SP analysis is that M -/-B +/+ bone marrow cells had consistently higher SP cells than that of the M +/+ B +/+ bone marrow cells (0.63% ± 0.26 vs. 0.37% ± 0.25), although the difference did not reach statistical significance (P = 0.14) ( Table 2) . This is probably due to the difference in the genetic background of these mice. We found that FVB mice had higher numbers of SP cells than mice on a C57BL/6J background (data not shown). 
Mdr1 and Bcrp1 Provide Additive Protection to Hematopoietic Cells Against the Toxicity of Mitoxantrone
It has been shown that fibroblasts derived from embryos of M -/-B +/+ mice are more sensitive to paclitaxel and other (Figure 3, A-C) . These results suggest that Mdr1a/1b and Bcrp1 may provide additive protection to these cells, although the protection is modest due to their low expression level. A potentially stronger additive protection to HSCs may be conferred by the relatively higher level of coexpression of Mdr1 and Bcrp1 in these cells. These results also suggest that the use of Mdr1 and/or Bcrp1 inhibitors to sensitize drug-resistant tumor cells could cause severe hematopoietic toxicity. In summary, Mdr1a/1b and Bcrp1 are not required for the normal development of the hematopoietic compartment in mice but may provide additive protection to HSCs against the toxicities of a wide variety of xenobiotics. Bcrp1 is exclusively responsible for the SP phenotype in HSCs, while Mdr1 may account for some SP cells that are more mature. Further analysis of long-term repopulating HSC level and self-renewal capacity, using M -/-B -/-mice that are on a pure genetic background and in a transplantation assay, will definitively answer whether these two transporters have any other roles in HSC development.
